ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Forms Office of Combination Products;

January 10, 2003

In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science

January 13, 1995

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978

List of 100 Highest-Paid NIH Officials

February 12, 2010